"Pill-Based Cancer Prevention Shows Tremendous Benefit for Esophagus, Says Doctor"
Lucid Diagnostics has developed EsoGuard, a vitamin-sized pill for esophageal cancer screening, targeting those with chronic heartburn, obesity, family history, and a history of smoking. The test aims to detect precancerous conditions caused by GERD, offering a new line of defense against a cancer with a low survival rate. The pill collects cells from the esophagus for analysis, providing a positive or negative result. The test has an 85% sensitivity and a 99% predictive value, and is seen as a safe and simple alternative to invasive endoscopies. Early detection could prevent esophageal cancer, which has historically been difficult to screen for.